ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

Andrew Law / Caxton

directional-only · 31-MAR-2026 → 30-JUN-2026

AUM $1,853,427 · 10 positions · top-10 100.0% · SEC filing history →

13FScore 68/100 — cloning their disclosed top holdings over ~4.8y returned +13%/yr vs S&P +11%/yr (alpha +2%/yr), ahead of the market in 55% of quarters. Cloneable 13F equity book only — excludes hedges/shorts/non-US.

New positions

Issuer% bookValueSince entryConvictionBusinessTags
$SPCX · SPACE EXPLORATION TECHN CORP24.0%$445,346-9%HighNASDAQSerenityBitget →
$GOOGL · ALPHABET INC13.3%$246,906-2%HighAlphabet is the holding company for Google, generating revenue from search and advertising, YouTube, Android, Google Cloud, and other technology businesses.NASDAQS&PCitriniSerenityBitget →
$VOO · Vanguard S&P 500 ETF12.6%$233,094+4%HighVanguard S&P 500 ETFBitget →
$BX · BLACKSTONE INC10.2%$188,218+5%HighBlackstone is a leading alternative-asset manager investing across private equity, real estate, credit, and hedge-fund strategies on behalf of institutional and individual investors.S&PBitget →

Added to (≥+25% shares)

Issuer% bookΔ sharesSince addConvictionBusinessTags
none

Top holdings now

Issuer% bookSince entryBusinessTags
$SPCX · SPACE EXPLORATION TECHN CORP24.0%-9% Q2 '26NASDAQSerenityBitget →
$BRK.B · BERKSHIRE HATHAWAY INC DEL20.3%+41% Q4 '23Berkshire Hathaway is a diversified holding company led by Warren Buffett, owning insurance, railroad, energy, and manufacturing businesses alongside a large portfolio of public equities.S&PCitriniBitget →
$GOOGL · ALPHABET INC13.3%-2% Q2 '26Alphabet is the holding company for Google, generating revenue from search and advertising, YouTube, Android, Google Cloud, and other technology businesses.NASDAQS&PCitriniSerenityBitget →
$VOO · Vanguard S&P 500 ETF12.6%+4% Q2 '26Vanguard S&P 500 ETFBitget →
$BX · BLACKSTONE INC10.2%+5% Q2 '26Blackstone is a leading alternative-asset manager investing across private equity, real estate, credit, and hedge-fund strategies on behalf of institutional and individual investors.S&PBitget →
$KYTX · KYVERNA THERAPEUTICS INC5.9%-70% Q1 '24Cell therapy biotech for autoimmune diseasesNASDAQ
$LXEO · LEXEO THERAPEUTICS INC4.3%-70% Q4 '23Gene therapy biotech (cardiac, CNS diseases)NASDAQ
$XFOR · X4 PHARMACEUTICALS INC3.9%-14% Q4 '25Biotech for rare immune diseasesNASDAQ
$IKT · INHIBIKASE THERAPEUTICS INC3.1%-29% Q4 '24Neurodegenerative disease therapeutics biotechNASDAQ
$ALXO · ALX ONCOLOGY HLDGS INC2.3%-20% Q1 '26NASDAQ

Since entry / add = price change to the latest close (30-JUN-2026 book marked to market). Top holdings measure from the quarter-end when the name first entered the filer's disclosed top holdings (tagged e.g. Q1 '26); new & added positions measure from this quarter's quarter-end. Based on disclosed 13F snapshots — an approximation of entry, not the manager's actual cost basis. Generated 2026-09-24 · Alpha-Investor tracker